Real-world study of Surufatinib combined with hepatic artery infusion chemotherapy (HAIC) for high-grade neuroendocrine neoplasm

被引：0
|
作者：
Wang, Y. [1 ]
Yu, H. [1 ]
Yang, D. [1 ]
Liu, H. [1 ]
Yao, W. [1 ]
Chen, L. [1 ]
Liu, M. [1 ]
Zhang, N. [1 ]
机构：
[1] Zhongshan Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2024年 / 36卷
关键词：
real-world study; surufatinib; hepatic artery infusion chemotherapy; high-grade neuroendocrine neoplasm;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
I32
引用
收藏
页码：256 / 256
页数：1
相关论文
共 50 条
  • [21] A phase II study to evaluate the efficacy and safety of fruquintinib combined with tislelizumab and Hepatic Artery Infusion Chemotherapy (HAIC) for advanced Colorectal Cancer Liver Metastases (CRLM)
    Wang, L.
    Zhang, T.
    Zhao, Y.
    Pan, Q.
    Mao, A.
    Zhu, W.
    Feng, Y.
    Zhou, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S451 - S451
  • [22] Implementation of Hepatic Artery Infusion Pump Therapy: Real-World Single-Center Experience
    Connor Chick, Robert
    Ruff, Samantha M.
    Monasterio, Julia
    Neilson, Taylor
    Tsai, Susan
    Ejaz, Aslam
    Tsung, Allan
    Kim, Alex C.
    JOURNAL OF SURGICAL ONCOLOGY, 2024,
  • [23] Efficacy and safety of surufatinib in unresectable or metastatic grade 3 pancreatic neuroendocrine tumors (NET G3): Real-world analysis.
    Wang, Jian
    Liang, Yun
    Long, Jiang
    Chi, Yihebali
    Zhang, Suzhen
    Wu, Yinying
    Wang, Yu
    Bai, Chunmei
    Hu, Weiyu
    Hu, Hanguang
    Zhang, Lin
    Chen, Jie
    Hao, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 657 - 657
  • [24] Hepatic arterial infusion chemotherapy (HAIC) combined with Tislelizumab and Lenvatinib for unresectable hepatocellular carcinoma: a retrospective single-arm study
    Sun, Ruirui
    Gou, Yang
    Pan, Long
    He, Qiang
    Zhou, Yin
    Luo, Yi
    Wu, Chenrui
    Zhao, Yaowu
    Fu, Zixuan
    Huang, Ping
    CELLULAR ONCOLOGY, 2024, : 2277 - 2278
  • [25] Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting
    Liontos, Michalis
    Papatheodoridi, Alkistis
    Andrikopoulou, Angeliki
    Thomakos, Nikolaus
    Haidopoulos, Dimitrios
    Rodolakis, Alexandros
    Zagouri, Flora
    Bamias, Aristotelis
    Dimopoulos, Meletios-Athanasios
    CURRENT ONCOLOGY, 2021, 28 (02) : 1143 - 1152
  • [26] Donafenib combined with hepatic artery infusion chemotherapy (HAIC) and sintilimab for unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II trial (DoHAICs study).
    Zhang, Wei
    Gao, Wei
    Liu, Chen
    Li, Guangtao
    Zhang, Qin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Prognostic factors and nomogram for pulmonary resected high-grade neuroendocrine carcinomas: a 20-year single institutional real-world experience
    Liu, Lei
    Zhang, Jiaqi
    Zhao, Ke
    Guo, Chao
    Huang, Cheng
    Li, Shanqing
    Chen, Yeye
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [28] Continuous infusion of Endostar combined with chemotherapy in patients with advanced or recurrent mucosal melanoma: A real-world cohort study.
    Liu, Xin
    Jiang, Shiyu
    Zhang, Xiaowei
    Jin, Feng
    Cao, Jun
    Meng, Yanchun
    Xu, Yu
    Wang, Chunmeng
    Chen, Yong
    Yang, Huijuan
    Kong, Yunyi
    Luo, Zhiguo
    Hu, Xichun
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [29] Camrelizumab combined with apatinib and hepatic artery infusion chemotherapy (HAIC) as conversion therapy for patients with unresectable hepatocellular carcinoma(HCC): A single-arm exploratory clinical study
    Zhao, Lei
    Zhang, Bo
    Shi, Xuetao
    Cui, Kai
    Zhang, Jianxin
    Zhong, Jingtao
    Li, Zhongchao
    Sun, Pengfei
    Zhang, Chengsheng
    Li, Lei
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib Plus Humanized Programmed Death Receptor-1 in Patients with High-Risk Advanced Hepatocellular Carcinoma: A Real-World Study
    Chang, Xu
    Wu, Huiyong
    Ning, Shangkun
    Li, Xinge
    Xie, Yinfa
    Shao, Wenbo
    Yu, Jinming
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1497 - 1509
12345